James J Harding

43PUBLICATIONS
304CO-AUTHORS
Predictive and prognostic markersMolecular targetsChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Aug 04, 2026
Evaluating the Prognostic Impact of IDH Mutations in Intrahepatic Cholangiocarcinoma.

|Jun 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

|Apr 16, 2026
BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.

|Feb 19, 2026
Shaping the Future of HER2-Directed Therapy in Biliary Tract Cancer.

Orla M Fitzpatrick, James J Harding

|Feb 10, 2026
How I Do It: Systemic Therapies for Primary Liver Cancers.

Tae-Hyung Kim, James J Harding, Victoria Chernyak

|Jan 07, 2026
IL10R Inhibition Induces Neutrophil Tumoricidal Activity.

Danny N Khalil, Ricardo Gomez, Amit Regev

Pageof 8

Frequent Collaborators

18 joint publications

Ghassan K Abou-Alfa

14 joint publications

Eileen O'Reilly

11 joint publications

William R Jarnagin

10 joint publications

Alice Wei